/
Surgical & medical instruments & apparatus company · F4 · FY ends Sep · Revenue $10M · -4.24% margin · $5M FCF
The business is unprofitable at the operating level (-4.24% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue declined 14.4% YoY. The question is whether this is cyclical or a structural shift.
Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.
Profitability & Returns
Revenue (TTM)
$10M
▼ -14.4% YoY
Net Income (TTM)
-$1M
▲ +69.3% YoY
Op. Margin
-4.24%
▲ +13.1pp YoY
ROIC
-1.29%
▲ +5.7pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$5M
▲ +142.9% YoY
Op. Cash Flow (TTM)
$6M
▲ +380.3% YoY
Net Debt
$2M
Cash & Equiv.
$4M
3Y CAGR: -20.6%
Continue Research